![]() ![]() Results: With or without adjustment for covariates, there were no significant differences in testosterone, bioavailable testosterone, or SHBG levels by race/ethnicity. Main Outcome Measure(s): Testosterone, bioavailable testosterone, DHT, DHT to testosterone ratio, SHBG, and DHEAS were measured. Intervention: Intervention consisted of data obtained during in-person at-home interview, conducted by a bilingual phlebotomist/interviewer. Of 2301 men recruited, 1899 provided blood samples (538 black, 651 Hispanic, 710 white). Participants: Participants included black, Hispanic, or white individuals, aged 30–79 yr, competent to sign informed consent and literate in English/Spanish. Setting: The study was a community-based sample of Boston. ![]() Objective: The objective of the study was to investigate racial/ethnic variations in testosterone, bioavailable testosterone, dihydrotestosterone (DHT), SHBG, and dehydroepiandrosterone sulfate (DHEAS) levels.ĭesign: The Boston Area Community Health (BACH) Survey was a multistage stratified cluster random sample, recruiting from 2002 to 2005. Context: Racial/ethnic differences in androgen levels could account for differences in prostate cancer risk, body composition, and bone loss. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |